Printer Friendly
The Free Library
14,504,751 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Akorn, Inc. Reports First Quarter 2006 Revenues of $30 million, 40% Gross Margin and Diluted Earnings per Share of $0.04.


BUFFALO GROVE Buffalo Grove

A village of northeast Illinois, a suburb of Chicago. Population: 43,300.
, Ill. -- Akorn, Inc. (AMEX AMEX

See: American Stock Exchange
:AKN AKN King Salmon Airport (Alaska)
AKN Altona-Kaltenkirchen-Neumünster (public transportation system in the north of Hamburg, Germany)
AKN Net Cargo Ship (Auxiliary, Cargo, Net) 
) today reported net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 of $29.7 million for the first quarter 2006, an increase of 192% vs. first quarter 2005 net sales of $10.2 million. Gross profit of $11.7 million or 39.5% of first quarter 2006 net sales, represents an increase of 251% vs. gross profit of $3.3 million or 32.8% of net sales for the first quarter 2005. Net income for the first quarter 2006 was $3.1 million, or $0.04 per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 share vs. a $2.3 million net loss for the first quarter 2005 or $(0.13) per diluted share. Net income was adversely impacted by non-recurring interest expense of $1.1 million, due to the early retirement of convertible debt.

Highlights since the beginning of 2006 include:

--$21.4 million in net sales were recognized from an order with the Department of Health and Human Services Noun 1. Department of Health and Human Services - the United States federal department that administers all federal programs dealing with health and welfare; created in 1979
Health and Human Services, HHS
 for Ca-DTPA and Zn-DTPA, two countermeasures That form of military science that, by the employment of devices and/or techniques, has as its objective the impairment of the operational effectiveness of enemy activity. See also electronic warfare.  for a radiological radiological

pertaining to radiology.


radiological diagnosis
see radiological diagnosis.

mobile radiological apparatus
x-ray machines that can be moved but are not portable because of their weight.
 or nuclear incident.

--Three new definitive agreements were signed, two with Natco Pharma Pharma may be an abbreviation for:
  • Pharmaceutical company
  • Pharmaceutical drug
  • Pharmacology
  • Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Pharma (record label)
 Limited and one with Cipla CIPLA Chemical, Industrial & Pharmaceutical Laboratories , Ltd., that add five new drug products to Akorn's development pipeline.

--Two new drug product approvals were received from the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 for Brimonidine brimonidine /bri·mo·ni·dine/ (bri-mo´ni-den) an a agonist used as the tartrate salt in the treatment of open-angle glaucoma and ocular hypertension.  and Inapsine(R).

--Six ANDA's have been submitted. Three of these ANDA's are from Akorn-Strides, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, Akorn's joint venture with Strides Arcolab This article or section is written like an .
Please help [ rewrite this article] from a neutral point of view.
Mark blatant advertising for , using .
 Limited.

--$19.4 million in new capital was raised. Proceeds are intended for investment in manufacturing upgrades at our Decatur Decatur.

1 City (1990 pop. 48,761), seat of Morgan co., N Ala., on the Tennessee River; inc. 1826. It has shipyards, port traffic, and diverse industries, including steel manufacturing.
, IL manufacturing facility and for clinical product development efforts.

--For the first quarter 2006, cash flow from operations Cash flow from operations

A firm's net cash inflow resulting directly from its regular operations (disregarding extraordinary items such as the sale of fixed assets or transaction costs associated with issuing securities), calculated as the sum of net income plus noncash expenses
 was $8.8 million.

--The Series A 6.0% Participating Convertible Preferred Stock Participating convertible preferred stock

Preferred stock that can be converted into common stock at the option of the holder. In contrast, to the usual preferred stock, the value of the preferred stock is refunded to the holder. That is, one gets conversion plus the value of the stock.
 was retired and converted to 36,796,755 shares of common stock.

--$10.6 million in outstanding debt was retired.

Akorn Reiterates its Outlook for 2006:

--50% Revenue growth generated from new product introductions, increased contract manufacturing business, and our exclusive license for Ca-DTPA and Zn-DTPA.

--40% Gross Margin.

--Positive Net Income.

--Significant Improvement in Cash Flow from Operations.

--Debt-free Balance Sheet.

--Lyophilization Manufacturing Facility Fully Operational.

Arthur Arthur, king of Britain: see Arthurian legend.

Arthur

king and hero of Scotland, Wales, and England. [Arthurian Legend: Parrinder, 28]

See : Heroism
 S. Przybyl, President and Chief Executive Officer stated, "We executed on all fronts, revenues, margins, earnings and cash flow. Our Business Development activities continue to expand our development pipeline. At the Decatur, IL manufacturing facility, product approvals have begun and we continue to progress operational qualification efforts for our lyophilization lyophilization /ly·oph·i·li·za·tion/ (li-of?i-li-za´shun) the creation of a stable preparation of a biological substance by rapid freezing and dehydration of the frozen product under high vacuum.  facility. Company-wide anticipated regulatory reg·u·late  
tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates
1. To control or direct according to rule, principle, or law.

2.
 filings are on schedule for 2006.

"Days on-hand inventory levels at wholesalers have been reduced by 37% from year-end year-end also year·end
n.
The end of a year.

adj.
Occurring or done at the end of the year: a year-end audit.

Noun 1.
 2005 and wholesaler throughput The speed with which a computer processes data. It is a combination of internal processing speed, peripheral speeds (I/O) and the efficiency of the operating system and other system software all working together.

1.
 sales have increased by 20%. This bodes well for our future revenues and operating margins Operating Margin

A ratio used to measure a company's pricing strategy and operating efficiency.

Calculated by:
. Our cash on hand is $24.6 million and we have effectively retired all of our outstanding debt."

Conference Call

Akorn will host a conference call on Monday Monday: see week. , May 1, 2006, beginning at 5:00 p.m. Eastern Time to discuss first quarter 2006 operating results. Analysts, investors and other interested parties are invited to participate by visiting the Company's website, www.akorn.com, and clicking on the live webcast icon located on the home page, or http://www.videonewswire.com/event.asp?id=33476. Please plan to or log on at least ten minutes prior to the designated start time so management may begin promptly prompt  
adj. prompt·er, prompt·est
1. Being on time; punctual.

2. Carried out or performed without delay: a prompt reply.

tr.v.
.

About Akorn, Inc.

Akorn, Inc. manufactures and markets sterile sterile /ster·ile/ (ster´il)
1. unable to produce offspring.

2. aseptic.


ster·ile
adj.
1. Not producing or incapable of producing offspring.

2.
 specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois
For other uses, see Decatur.
Decatur is the largest city and the county seat of Macon County in the U.S. state of Illinois. The city, known as "The Soybean Capital of the World" was founded in 1836 and is located in Central Illinois along the Sangamon
 and Somerset, New Jersey Somerset is a census-designated place and unincorporated area located at the eastermost section within Franklin Township, in Somerset County, New Jersey. As of the United States 2000 Census, the CDP population was 23,040. Somerset housed one of the first Marconi Wireless Stations.  and markets and distributes an extensive line of hospital and ophthalmic ophthalmic /oph·thal·mic/ (of-thal´mik) ocular (1).

oph·thal·mic
adj.
Of or relating to the eye; ocular.


Ophthalmic
Pertaining to the eye.
 pharmaceuticals. Additional information is available at the Company's website at www.akorn.com.

Materials in this press release may contain information that includes or is based upon forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 Reform Act of 1995. Forward-looking statements give our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 future steps we may take, prospective products, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies Contingencies (ISSN 1048-9851) is the bimonthly magazine of the American Academy of Actuaries, providing a large and diverse readership with general interest and technical articles on a wide range of issues related to the actuarial profession.  such as legal proceedings All actions that are authorized or sanctioned by law and instituted in a court or a tribunal for the acquisition of rights or the enforcement of remedies. , and financial results.

Any or all of our forward-looking statements here or in other publications may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed. Our actual results may vary materially, and there are not guarantees about the performance of our stock.

Any forward-looking statements represent our expectations or forecasts only as of the date they were made and should not be relied upon as representing our expectations or forecasts as of any subsequent date. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise, even if our expectations or forecasts change. You are advised, however, to consult any further disclosures we make on related subjects in our reports filed with the SEC. In particular, you should read the discussion in the section entitled en·ti·tle  
tr.v. en·ti·tled, en·ti·tling, en·ti·tles
1. To give a name or title to.

2. To furnish with a right or claim to something:
 "Cautionary Statement Regarding Forward-Looking Statements" in our most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, as it may be updated in subsequent reports filed with the SEC. That discussion covers certain risks, uncertainties and possibly inaccurate assumptions that could cause our actual results to differ materially from expected and historical results. Other factors besides those listed there could also adversely affect our results.
AKORN, INC.
                 CONDENSED CONSOLIDATED BALANCE SHEETS
                             IN THOUSANDS
                              (UNAUDITED)

                                              MARCH 31,   DECEMBER 31,
                                                 2006         2005
                                             ------------ ------------
ASSETS
CURRENT ASSETS
  Cash and cash equivalents                      $24,558         $791
  Trade accounts receivable (less allowance
   for doubtful accounts of $3 and $13
   respectively)                                   2,031        3,222
  Inventories                                     10,966       10,279
  Prepaid expenses and other current assets        1,593        1,402
                                             ------------ ------------
    TOTAL CURRENT ASSETS                          39,148       15,694
PROPERTY, PLANT AND EQUIPMENT, NET                31,322       31,071
OTHER LONG-TERM ASSETS
  Intangibles, net                                 9,859       10,210
  Other                                              113          120
                                             ------------ ------------
    TOTAL OTHER LONG-TERM ASSETS                   9,972       10,330
                                             ------------ ------------
    TOTAL ASSETS                                 $80,442      $57,095
                                             ============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
  Current installments of debt                      $373       $7,044
  Trade accounts payable                           2,745        3,046
  Accrued compensation                             1,063        1,519
  Customer accrued liabilities                     3,115          135
  Accrued Interest Payable                            --        2,514
  Accrued expenses and other liabilities           1,180        1,202
                                             ------------ ------------
    TOTAL CURRENT LIABILITIES                      8,476       15,460
LONG-TERM LIABILITIES
  Long-term debt, less current installments          506          602
  Product Warranty                                 1,159           --
                                             ------------ ------------
    TOTAL LONG-TERM LIABILITIES                    1,665          602
                                             ------------ ------------
      TOTAL LIABILITIES                           10,141       16,062
                                             ------------ ------------
SHAREHOLDERS' EQUITY
  Common stock, no par value -- 150,000,000
   shares authorized; 74,281,973 and
   27,618,745 shares issued and outstanding
   at March 31, 2006 and December 31, 2005,
   respectively                                  122,312       67,339
  Series A Preferred Stock, $1.00 par value,
   257,172 shares authorized and issued,
   241,122 shares outstanding at December
   31, 2005                                           --       27,232
  Series B Preferred Stock, $1.00 par value,
   170,000 shares authorized, 141,000 shares
   issued, 85,400 outstanding at March 31,
   2006 and 106,600 outstanding at December
   31, 2005                                        8,757       10,758
  Warrants to acquire common stock                14,424       13,696
  Accumulated deficit                            (75,192)     (77,992)
                                             ------------ ------------
    TOTAL SHAREHOLDERS' EQUITY                    70,301       41,033
                                             ------------ ------------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY       $80,442      $57,095
                                             ============ ============


                              AKORN, INC.
            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                  IN THOUSANDS, EXCEPT PER SHARE DATA
                              (UNAUDITED)

                                                THREE MONTHS ENDED
                                                     MARCH 31,
                                                 2006         2005
                                             ------------ ------------
Revenues                                         $29,730      $10,181
Cost of sales                                     17,997        6,838
                                             ------------ ------------
   GROSS PROFIT                                   11,733        3,343
Selling, general and administrative expenses       4,484        3,368
Amortization and write-down of intangibles           351          379
Research and development expenses                  2,045        1,342
                                             ------------ ------------
   TOTAL OPERATING EXPENSES                        6,880        5,089
                                             ------------ ------------
   OPERATING INCOME (LOSS)                         4,853       (1,746)
Interest expense                                  (1,319)        (526)
Debt Retirement Expense                             (391)          --
Other Income (Expense)                               (17)          --
                                             ------------ ------------
   INCOME (LOSS) BEFORE INCOME TAXES               3,126       (2,272)
Income tax provision (benefit)                        --           15
                                             ------------ ------------
   NET  INCOME (LOSS)                              3,126       (2,287)
Preferred stock dividends and adjustments           (326)      (1,061)
                                             ------------ ------------
   NET INCOME (LOSS) AVAILABLE TO COMMON
    STOCKHOLDERS                                  $2,800      $(3,348)
                                             ============ ============
NET INCOME (LOSS) PER SHARE:
  BASIC                                            $0.05       $(0.13)
                                             ============ ============
  DILUTED                                          $0.04       $(0.13)
                                             ============ ============
SHARES USED IN COMPUTING
  NET INCOME (LOSS) PER SHARE:
  BASIC                                           61,715       25,237
                                             ============ ============
  DILUTED                                         74,980       25,237
                                             ============ ============


                              AKORN, INC.
            CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                             IN THOUSANDS
                              (UNAUDITED)

                                                THREE MONTHS ENDED
                                                     MARCH 31,
                                                 2006         2005
                                             ------------ ------------
OPERATING ACTIVITIES
Net income (loss)                                 $3,126      $(2,287)
Adjustments to reconcile net income (loss)
 to net cash used in operating activities:
  Depreciation and amortization                      818        1,751
  Amortization of debt discounts                   1,059          253
  Advances to Strides Arcolab Limited                 --       (1,500)
  Non-cash stock compensation expense                333           --
   Changes in operating assets and
    liabilities:
    Trade accounts receivable                      1,191        3,228
    Inventories                                     (687)        (272)
    Prepaid expenses and other current
     assets                                         (184)         272
    Trade accounts payable                          (301)      (2,625)
    Product warranty                               1,159           --
    Accrued Customer Liability                     2,980           --
    Accrued expenses and other liabilities          (694)         105
                                             ------------ ------------
NET CASH PROVIDED BY (USED IN) OPERATING
 ACTIVITIES                                        8,800       (1,075)
INVESTING ACTIVITIES
Purchases of property, plant and equipment          (718)         (83)
Purchase of intangible assets                         --          (75)
                                             ------------ ------------
NET CASH PROVIDED BY (USED IN) INVESTING
 ACTIVITIES                                         (718)        (158)
FINANCING ACTIVITIES (see Note 1 below)
Repayment of long-term debt                       (2,826)         (83)
Proceeds from common stock & warrants
 offering                                         18,078           --
Proceeds from warrants exercised                      95           37
Proceeds under stock option and stock
 purchase plans                                      338          388
                                             ------------ ------------
NET CASH PROVIDED BY (USED IN) FINANCING
 ACTIVITIES                                       15,685          342
                                             ------------ ------------
INCREASE (DECREASE) IN CASH AND CASH
 EQUIVALENTS                                      23,767         (891)
Cash and cash equivalents at beginning of
 period                                              791        4,110
                                             ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF PERIOD       $24,558       $3,219
                                             ============ ============

Amount paid for interest (net of capitalized
 interest)                                          $542          $25
Amount paid/(refunded) for income taxes                2           72


Note 1: $7,298 in principal and interest related to convertible
        subordinated notes was retired in March 2006 by conversion to
        the common stock of Akorn, Inc.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 1, 2006
Words:1680
Previous Article:Chipotle Mexican Grill, Inc. to Announce First Quarter 2006 Results on May 8, 2006.
Next Article:VISICU Reports First Quarter Results.
Topics:



Related Articles
Akorn Reports First Quarter Results; Discusses 1998 Outlook.
Akorn, Inc. Reports Record Third Quarter and Nine Months Results.
Akorn, Inc. Reports Year End 2005 Results and Provides Outlook for 2006.
Itron Announces Record First Quarter Revenue and Earnings; GAAP EPS of 27 cents and Pro Forma EPS of 58 cents on Revenues of $155.6 Million; $206...
Akorn, Inc. Reports Second Quarter 2006 Revenues Of $12.5 Million And 40% Gross Margin.
Checkpoint Systems, Inc. Announces Second Quarter 2006 Results.
Intevac Inc. Reports Financial Results for Second-Quarter 2006; Record Quarterly Revenue.
Jones Soda Co. Announces Record 2006 Second Quarter Financial Results.
Akorn, Inc. Reports Third Quarter 2006 Revenues of $14.5 million and 41% Gross Margin.
Akorn Reports First Quarter 2007 Financial Results.(Financial report)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles